Apoptosis and Morphologic Changes in Drug-Treated Trabecular Meshwork Cells In Vitro
Transcript of Apoptosis and Morphologic Changes in Drug-Treated Trabecular Meshwork Cells In Vitro
Exp. Eye Res. (1998) 66, 521–529
Apoptosis and Morphologic Changes in Drug-Treated Trabecular
Meshwork Cells In Vitro
SANTIAGO ANTONIO B. SIBAYANa*, MARK A. LATINAa, MARGARET E. SHERWOODa,
THOMAS J. FLOTTEa KRISTIN WHITEb
a Wellman Laboratories of Photomedicine and b Cutaneous Biology Research Center, Department
of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, U.S.A.
(Received Columbia 10 September 1997 and accepted in revised form 11 November 1997)
Using an in vitro culture system, we investigated whether bovine trabecular meshwork cells undergoapoptosis (programmed cell death) following exposure to anti-glaucoma medications (timolol, pilocarpineand epinephrine) and known inducers of apoptosis (5-fluorouracil, mitomycin-C and dexamethasone).Third to fifth passage bovine trabecular meshwork cells were grown to confluence and incubated for 1–12days in growth media with timolol (1–1000 µ), pilocarpine (15–15000 µ), epinephrine (5–5000 µ),5-fluorouracil (10–100 µg ml−"), mitomycin-C (0±01–100 µg ml−") and dexamethasone (0±01–100 µ).The cultures were evaluated for apoptosis by phase-contrast microscopy, transmission electronmicroscopy and in situ apoptosis labeling. 5-Fluorouracil (10–100 µg ml−"), mitomycin-C (0±1–100 µgml−") and epinephrine (500–5000 µ) induced apoptosis in a dose and time-dependent manner. Timolol,pilocarpine, and dexamethasone-treated specimens did not show evidence of apoptosis at any of theconcentrations tested. Trabecular meshwork cells incubated in timolol (100–1000 µ) developedcytoplasmic granules, and specimens treated with pilocarpine (15000 µ) developed cytoplasmicvacuoles. These granules and vacuoles have the appearance of secondary lysosomes. Dexamethasone-treated cells developed an increased number of mitochondria. This study suggests that the trabecularmeshwork may undergo apoptosis following exposure to 5-fluorouracil, mitomycin-C and epinephrine.Timolol, pilocarpine and dexamethasone did not induce apoptosis. However, these drugs can incitecharacteristic morphologic changes in cultured trabecular meshwork cells.
# 1998 Academic Press LimitedKey words : apoptosis ; dexamethasone; epinephrine; 5-fluorouracil ; mitomycin-C; pilocarpine; timolol ;
trabecular meshwork.
1. Introduction
Apoptosis (programmed cell death) is a gene-regulated
process that plays an important role in the normal
physiologic turnover of cells and in various patho-
logical processes. It may occur spontaneously or in
response to physiologic stimuli. Apoptosis may also be
induced by exogenous toxic agents (Kerr, Wyllie and
Currie, 1972; Duvall and Wyllie, 1986; Kerr et al.,
1987; Schwartzman and Cidlowski, 1993).
Characteristic morphologic and biochemical
features distinguish apoptosis from necrosis. Mor-
phologic changes in necrosis include cell swelling,
degradation of organelles, rupture of cell membranes,
and spillage of cellular contents into the extracellular
space, resulting in an inflammatory response (Duvall
and Wyllie, 1986; Kerr et al., 1987; Schwartzman
and Cidlowski, 1993). In contrast, apoptosis is
characterized by condensation and margination of
chromatin, structural disorganization of the nucleus,
and formation of cell fragments or ‘apoptotic bodies ’.
Apoptotic bodies maintain intact organelles and cell
membranes, and are engulfed by neighboring phago-
cytic cells, thus no inflammatory response is elicited
* For correspondence at : Medico Building, Room 401, SanMiguel Avenue, 1600 Pasig City, Philippines.
(Kerr et al., 1972, 1987; Duvall and Wyllie, 1986;
Schwartzman and Cidlowski, 1993). Some apoptotic
bodies, however, may escape phagocytosis and under-
go swelling and degradation of intracellular content, a
process referred to as ‘secondary degeneration’ (Searle
et al., 1975; Don et al., 1977; Duvall and Wyllie,
1986; Kerr et al., 1987; Schwartzman and Cidlowski,
1993). Biochemical changes in apoptosis are charac-
terized by enzymatic cleavage of DNA by endogenous
endonuclease, often into multiples of 180–200 base
pairs (Wyllie, 1980; Duvall and Wyllie, 1986;
Schwartzman and Cidlowski, 1993). In necrosis, DNA
is cleaved into segments of random length (Afanas’ev
et al., 1986).
Trabecular meshwork (TM) cells perform a variety
of activities in maintaining the normal function of the
aqueous outflow pathway. It has been reported that
loss of TM cells occurs with age. Such loss is greater
in eyes with open-angle glaucoma, as compared
to non-glaucomatous age-matched eyes (Alvarado,
Murphy and Juster, 1984). It has also been proposed
that chronic administration of anti-glaucoma medi-
cations may promote loss and further damage of
already diseased TM cells (Watson and Grierson,
1981; Grierson et al., 1982). Whether apoptosis plays
a role in the loss of TM cells has thus far not been
investigated.
0014–4835}98}05052109 $25.00}0}ey970458 # 1998 Academic Press Limited
522 S. A. B. SIBAYAN ET AL.
In this study, we investigated whether TM cells can
undergo apoptosis in vitro following exposure to anti-
glaucoma medications (timolol, pilocarpine and epi-
nephrine) and known inducers of apoptosis [5-
fluorouracil (5-FU) (Barry, Behnke and Eastman,
1990; Lowe et al., 1993), mitomycin-C (MMC) (Searle
et al., 1975; Ohmori et al., 1993; Rey, Scott and
Mu$ ller, 1994) and dexamethasone (Cohen and Duke,
1984; Compton and Cidlowski, 1986; Kawabori et al.,
1991; Hassan et al., 1996; Zysk et al., 1996)]. In
addition to being known inducers of apoptosis, 5-FU
and MMC are used adjunctively during glaucoma
filtration surgery (Heuer et al., 1986; Chen et al.,
1990; Palmer, 1991), and dexamethasone is used as
an anti-inflammatory agent.
2. Materials and Methods
Bovine Trabecular Meshwork Cell Cultures
Primary TM cell cultures were prepared from fresh
bovine eyes obtained from a local slaughterhouse.
Trabecular tissue was excised from the eyes within
6 hr of the animal’s death. Dissection was performed
under sterile conditions with the aid of a stereo-
microscope (Typ 355110, Wild Inc., Heerbrugg,
Switzerland). The trabecular tissue was cultured on
35 mm plastic petri dishes (Falcon}Becton-Dickinson,
Franklin Lakes, NJ, U.S.A.) and left undisturbed for 1
week to allow the cells to plate onto the dish. The
growth media consisted of Dulbecco’s Modified Eagle
Medium (D-MEM) with 10% fetal bovine serum, 1%
penicillin-streptomycin, and 1% amphotericin B
(Gibco, Buffalo, NY, U.S.A.). The cultures were
maintained in an atmosphere of 5% carbon dioxide,
95% relative humidity, at a temperature of 37°C. The
cells were subsequently trypsinized and cultured in
tissue culture flasks (Falcon}Becton-Dickinson, Frank-
lin Lakes, NJ, U.S.A.). Cells used for our experiments
were in the third to fifth passages, and were grown to
confluence in 35 mm plastic petri dishes.
Drug Solutions
Bovine TM cell cultures were incubated in the
following drugs (Sigma Chemical Co., St. Louis, MO,
U.S.A.) dissolved in the previously described culture
media at various specified concentrations : 5-FU
(10–100 µg ml−"), MMC (0±01–100 µg ml−"), dexa-
methasone (0±01–100 µ), timolol (1–1000 µ), pilo-
carpine (15–15000 µ) and epinephrine (5–
5000 µ). Cultures treated with 5-FU, MMC, pilo-
carpine and epinephrine were incubated for a maxi-
mum of 7 days, while those treated with timolol and
dexamethasone were incubated for 12 days. Cell
cultures incubated in drug-free media served as
controls. All experiments were performed in quad-
ruplicate.
The drug concentration ranges used in this study
are similar to those used by Kawa et al. (1993) in their
study on the effect of anti-glaucoma medications on
bovine TM cell morphology. The peak drug levels
achieved in the aqueous humor following topical
administration in vivo served as the basis for the
concentration ranges tested. It has been estimated that
30 minutes after applying 0±5% timolol in rabbits, the
aqueous levels reach 1–5 µ (Polansky and Alvarado,
1985; Ellis, Wu and Riegel, 1991). The concentration
of pilocarpine in aqueous humor has been determined
to reach 15–20 µ 30 minutes after administration of
2% or 4% pilocarpine (Ellis, Matsumura and Rendi,
1985; Ellis et al., 1991). One hr after topical appli-
cation of 1% epinephrine eye drops in cynomolgus
monkeys, aqueous levels can reach 40 µ (Kaufman
and Rentzhog, 1981). Ninety to 120 minutes after
administration of 0±1% dexamethasone alcohol, aq-
ueous levels approach 0±1 µ (Watson et al., 1988).
One hour after subconjuctival administration of
12±5 mg 5-FU, levels ranging from 65±7–69±5 µg
ml−" of aqueous humor have been reported (Rootman
et al., 1979; Fantes et al., 1987). MMC can reach
levels of up to 0±2 µg ml−" in the aqueous humor 30
minutes after intraoperative application of a 0±2 mg
0±5 ml−" solution (Kawase et al., 1992; Seah et al.,
1993).
Morphology Studies
TM cell cultures were evaluated daily for mor-
phologic changes by phase contrast microscopy with
the use of an inverted microscope (Model IM 35, Carl
Zeiss, Go$ ttingen, Germany). Changes in morphology
were documented photographically.
For transmission electron microscopy studies, TM
cells were plated on 1 cm glass cover slips in 24-well
cell culture plates and incubated in media as previously
described. Following incubation in the different drug
solutions, specimens were fixed in 4% glutaraldehyde
for 1 hr at room temperature, and transferred to
cacodylate buffer solution. Cells were post-fixed in 2%
osmium tetroxide in 0±1 sodium cacodylate buffer,
pH 7±4, for 1 hr at room temperature. The cell
monolayers on coverslips were processed through
ethanol dehydration, infiltrated with increasing per-
centages of Epon 812:ethanol (Electron Microscopy
Sciences, Fort Washington, PA, U.S.A.) and embedded
with inverted Beem capsules placed directly over the
coverslips. The blocks were sectioned and sub-
sequently examined with a transmission electron
microscope (Model CM-10, Philips Corp., Eindhoven,
The Netherlands).
In Situ Apoptosis Staining
TM cells were processed for in situ labeling with the
TACS 1 Klenow Apoptosis Screening Kit (Trevigen
Inc., Gaithersberg, MD, U.S.A.). This assay is a
histochemical stain that is similar in principle to the
DRUG-INDUCED APOPTOSIS IN TRABECULAR CELLS 523
TdT-mediated dUTP nick end labeling (TUNEL) assay,
except that it labels 5«-overhangs, instead of 3«-OH
ends of DNA fragments that are generated during the
process of apoptosis. These overhangs are end-labeled
with biotinylated nucleotides and are tagged with
streptavidin-horseradish peroxidase, which in turn, is
made to react with diaminobenzidine (DAB), resulting
in a brown precipitate. Non-apoptotic cells have
relatively insignificant amounts of 5«-overhangs, and
thus do not stain.
The following is a summary of the in situ staining
procedure. Following incubation with the various
drugs, the TM cell cultures were fixed in the petri
dishes for 30 minutes in 4% formaldehyde. The cells
were then washed three times in phosphate buffered
saline (PBS) for 2 minutes each wash. Cell membranes
were permeabilized by treating the samples with
0±7 mg% proteinase K solution at room temperature
for 5 minutes. Endogenous peroxidase activity was
quenched by immersing the specimens in 2% hydro-
gen peroxide at room temperature for 5 minutes. The
samples were rinsed for at least 1 minute by replacing
the hydrogen peroxide solution with Klenow labeling
buffer. The labeling buffer was aspirated, 100 µl
of Klenow labeling reaction mix were applied, and
plastic coverslips were placed over the specimens to
spread the reagent evenly. The specimens were then
placed in an incubator for 1 hr at a relative humidity
of 95% and a temperature of 37°C. The coverslips
were removed, and the labeling reaction was stopped
by immersion in stop buffer at room temperature for 5
minutes. The specimens were subsequently washed in
PBS for 2 minutes. One-hundred microliters of strepta-
vidin-horseradish peroxidase were applied on the
specimens and plastic coverslips were again applied to
spread the reagent evenly over the samples. The
specimens were incubated at room temperature for 20
minutes. The coverslips were then removed and the
samples were washed twice in PBS for 2 minutes each
wash. The specimens were immersed in DAB at room
temperature for 5–10 minutes until a satisfactory
color reaction was achieved. The specimens were
briefly rinsed in deionized water, and counterstained
by immersion in methyl green for 10 seconds. Methyl
green was then aspirated and replaced by PBS.
This assay was validated with the use of TACS Cell
Culture Control Slides (Trevigen Inc., Gaithersberg,
MD, U.S.A.). Specimens on these slides have been
ascertained to contain apoptotic (positive control) and
non-apoptotic (negative control) ML-1 cells.
Quantitation of Apoptotic Cells.
Quantitation of apoptotic cells was performed by
counting the number of apoptotic cells per 200¬field.
This figure was divided by the total number of cells
within the same field, yielding the percentage of
apoptotic cells within each specified field. Statistical
analyses were performed using the Student’s t test,
with a P value of less than 0±05 considered statistically
significant.
3. Results
5-FU (10–100 µg ml−"), MMC (0±1–100 µg ml−"),
and epinephrine (500–5000 µ) induced apoptosis in
TM cell cultures in a dose and time-dependent manner.
Specimens treated with these drugs underwent con-
densation of cytoplasm, and compaction and margi-
nation of chromatin, morphologic changes charac-
teristic of apoptosis [Fig. 1(B), (C), (D)]. They also
stained positively with the in situ apoptosis label [Fig.
2(B), (C), (D)].
Timolol, pilocarpine and dexamethasone-treated TM
cells did not show any morphologic changes consistent
with apoptosis, nor did they stain with the in situ
apoptosis label at any of the concentrations tested.
However, these drugs developed characteristic mor-
phologic changes as discussed below.
5-FU
Between 4 and 5 days of incubation in 100 µg ml−"
5-FU, 50% of cells were apoptotic (41±4% and 62±9%
at days 4 and 5 respectively). By day 7, 100% were
apoptotic. Cells incubated at lower concentrations
resulted in a lower percentage of apoptotic cells at
each time period. After 7 days of incubation in 5-FU,
all specimens had a significantly higher number of
apoptotic cells, as compared to the control (P!0±05)
[Fig. 3(A)].
Mitomycin C
After 2 days of incubation in 100 µg ml−" MMC,
almost half of the cells (46±3%) were apoptotic, and by
the third day, nearly all (96±5%) were apoptotic. It
took 6 days for the 10 µg ml−" MMC specimen to reach
100% apoptosis. Compared to the control, specimens
incubated in 0±1 µg ml−" and 1 µg ml−" had a sig-
nificantly greater number of apoptotic cells (P!0±05)
after 7 days of incubation in MMC. Control cells and
cells treated for 7 days in 0±01 µg ml−" MMC achieved
apoptosis levels of 7±37% and 8±92% respectively. The
difference between these values was statistically insig-
nificant (P¯0±09) [Fig. 3(B)].
Epinephrine
Apoptotic changes were observed in TM cell cultures
as early as 4 hr after incubation in 5000 µ epi-
nephrine. After 24 hr, 100% of cells were apoptotic.
After 2 days of incubation in 500 µ epinephrine,
23±1% of cells were apoptotic. On the third to seventh
days, a plateau was reached with 26±1–27±4% of the
total cell population being apoptotic. Apoptosis was
not observed after 7 days of incubation in 5 µ and
50 µ epinephrine [Fig. 3(C)].
524 S. A. B. SIBAYAN ET AL.
F. 1. Transmission electron micrographs of drug-treated TM cells. (A) Control cells. Cells treated with (B) 5-FU (50 µgml−"¬7 days), (C) MMC (1 µg ml−"¬7 days) and (D) epinephrine (5000 µ¬4 hr) demonstrate condensation of cytoplasm,and coalescence and margination of chromatin, morphologic features characteristic of apoptosis. These apoptotic bodies are
DRUG-INDUCED APOPTOSIS IN TRABECULAR CELLS 525
Timolol
Although TM cells incubated in timolol did not
demonstrate apoptosis, they underwent character-
istic morphologic changes. Specimens incubated in
1000 µ and 100 µ timolol became rounded, and
granules were noted to surround the nucleus [Fig.
1(E)]. Such changes began to manifest on the second
day of incubation in the cultures treated with 1000 µ
timolol and on the fifth day of incubation in those
treated with 100 µ timolol. Cells incubated in timolol
at lower concentrations did not show such changes.
None of the specimens stained with the in situ
apoptosis label [Fig. 2(E)].
Pilocarpine
No changes consistent with apoptosis were observed
in TM cells treated with pilocarpine. However, cells
incubated in 15000 µ pilocarpine were noted to
develop vacuoles by the first day of incubation [Fig.
1(F)]. By the third day, these cells began to detach
from the substrate. Some of these cells had disrupted
cell membranes and disorganized intracellular con-
tent, findings consistent with necrosis. Neither vacuo-
lation nor necrosis was observed in cells treated with
lower concentration levels (15–1500 µ) even after 7
days of incubation. In situ apoptosis staining was
negative in all specimens [Fig. 2(F)].
Dexamethasone
No morphologic changes consistent with apoptosis
were observed in any of the specimens treated with
dexamethasone. However, these cells demonstrated a
large number of mitochondria as compared to control
cells [Fig. 1(G)]. In situ apoptosis staining was negative
in all specimens [Fig. 2(G)].
4. Discussion
This study demonstrates that cultured bovine TM
cells can undergo apoptosis following exposure to 5-
FU, MMC and epinephrine. Timolol, pilocarpine and
dexamethasone did not induce apoptosis at the various
concentrations tested in vitro. However, these agents
can induce characteristic morphologic changes in
cultured bovine TM cells.
Many of the drug concentrations tested are much
higher than those observed following routine admini-
stration in vivo. Furthermore, cell cultures are
continuously bathed in drugs and are not subject to
the physiologic turnover of aqueous humor that takes
undergoing ‘secondary degeneration’, as indicated by degradation of organelles and vacuolation. (E) Timolol (1000 µ¬12days) induced development of cytoplasmic granules. (F) Pilocarpine (15000 µ¬3 days) treatment resulted in formation ofcytoplasmic vacuoles. These granules and vacuoles [as illustrated in figures (E) and (F), respectively] have the appearanceof secondary lysosomes. (G) Dexamethasone (100 µ¬12 days) treated cells exhibit an increased number of mitochondria.Magnification: (A)¯¬1450, (B)¯¬4700, (C)¯¬4900, (D)¯¬8700, (E)¯¬2000, (F)¯¬1650, (G)¯¬1700.
place in vivo. Since only a few cells undergo apoptosis
at any specific time point, and the kinetics of apoptosis
are rapid, detection of apoptosis can be difficult (Coles,
Burne and Raff, 1993). Administration of such high
drug doses may allow us to observe apoptotic changes
more readily.
A large number of cultured TM cells were needed for
these experiments, therefore bovine, rather than
human TM cells were used. Bovine cells grow faster
than human cells and are readily available from the
slaughterhouse (Kawa et al., 1993). Bovine TM cells
also appear to be a valid model for the determination
of drug effects in human cells, since their responses are
consistent with those reported for human cells (Kawa
et al., 1993).
Being known inducers of apoptosis, 5-FU and MMC
were primarily used to develop positive controls in TM
cells. However, it is known that these agents can be
detected in the aqueous humor when used adjunc-
tively glaucoma filtration surgery (Rootman et al.,
1979; Fantes et al., 1987). The observation that these
agents can induce apoptosis in TM cells may be of
limited clinical significance since glaucoma filtration
surgery is usually performed in cases of advanced
glaucoma where the TM is presumably already
profoundly compromised. Furthermore, these drugs
are not administered in a chronic fashion, and thus
may not have a sustained toxic effect.
It has been shown that agents that elevate cAMP
levels can induce apoptosis (McConkey, Orrenius and
Jondal, 1990). Tripathi, Tripathi and Millard (1989)
have shown that stimulation of beta-1 and beta-2
adrenergic receptors in TM cells in vitro causes a net
increase in cAMP levels. To our knowledge, our
current study is the first to show that epinephrine
can induce apoptosis in TM cells in vitro, presumably
by a beta-adrenergic}cAMP-mediated process. The
exact mechanism by which epinephrine induces
apoptosis in these cells will be a subject of further
investigation.
In contrast, Rinner et al. (1994) have shown that
epinephrine can trigger apoptosis in rat thymocytes in
vivo only if administered concomitantly with a beta-
blocker (propranolol). Epinephrine administered alone
or together with an alpha-blocker (phentolamine) did
not trigger an increase in apoptotic activity. These
findings suggest that apoptosis may be mediated by an
alpha-adrenergic receptor, and that beta-adrenergic
stimulation may counteract the apoptosis-inducing
activity of alpha-adrenergic receptors. Further studies
must be conducted in order to determine whether this
variation in biological response is due to a difference
between the two cell lines (rat thymocytes and bovine
526 S. A. B. SIBAYAN ET AL.
F. 2. In situ apoptosis staining of drug-treated TM cells in vitro. (A) Control cells do not exhibit staining. Positive stainingis demonstrated in cells treated with (B) 5-FU (50 µg ml−"¬7 days) (arrows), (C) MMC (1 µg ml−"¬7 days) (arrows), (D)epinephrine (5000 µ¬24 hr) (all cells). No staining is observed in cells treated with (E) timolol (1000 µ¬12 days), (F)pilocarpine (15000 µ¬3 days), and (G) dexamethasone (100 µ¬12 days). All photomicrographs, magnification¯¬200.
DRUG-INDUCED APOPTOSIS IN TRABECULAR CELLS 527
F. 3. Dose response curves illustrate the dose- and time-dependent inducement of apoptosis following treatment with(A) 5-FU, (B) MMC and (C) epinephrine.
TM cells), or a difference between cell responses in vivo
and in vitro.
If apoptosis in TM cells in vivo is mediated by beta-
adrenergic stimulation, administration of beta-
blockers may provide a protective effect in epinephrine-
treated eyes. On the other hand, if apoptosis is
mediated by an alpha-adrenergic receptor and beta-
blockade potentiates apoptosis, eyes treated concomi-
tantly with beta blockers and epinephrine may
undergo greater apoptotic changes in the TM as
compared to those that are treated with epinephrine
alone.
In addition to its use as an anti-glaucoma drug,
epinephrine is commonly used in ophthalmic surgery
as a mydriatic agent. Intraoperatively, solutions with
concentrations of up to 550 µ (1:10000 solution)
are injected directly into the anterior chamber. Using
such concentrations, the levels achieved within the
anterior chamber following intracameral administra-
tion could reach levels higher than those observed
following topical application. Intracameral adminis-
tration of epinephrine could therefore have greater
potential for acute cytotoxicity. Topical administra-
tion, on the other hand, results in sustained low levels
of epinephrine, which could result in chronic effects.
Timolol and pilocarpine-treated TM cells did not
exhibit any evidence of apoptosis. However, they
underwent characteristic morphologic changes which
have previously been described (Kawa et al., 1993).
Timolol-treated cells developed cytoplasmic granules,
and pilocarpine-treated specimens developed cyto-
plasmic vacuoles. These granules and vacuoles have
the appearance of secondary lysosomes. In addition,
we have demonstrated that high doses of pilocarpine
(15000 µ) can induce necrosis.
Steroids can induce glaucoma in certain susceptible
individuals (Bernstein and Schwartz, 1962; Armaly,
1963; Becker and Mills, 1963). Dexamethasone has
been shown to cause a decrease in the cellularity of the
TM of eyes that are prone to steroid-induced glaucoma
(Clark et al., 1995). Such a decrease could contribute
to the pathogenesis of this disease process. Steroids
have also been shown to induce apoptosis in certain
cells, such as thymocytes (Wyllie, 1980; Cohen
and Duke, 1984; Compton and Cidlowski, 1986),
eosinophils (Kawabori et al., 1991), leukemia cells
(McConkey et al., 1991) and neurons (Hassan et al.,
1996; Zysk et al., 1996). However, not all cells
are susceptible to dexamethasone-induced apoptosis
[e.g., HeLa S$
cells (Cidlowski and Cidlowski,
1981; Schwartzman and Cidlowski, 1991) and
glucocorticoid-resistant lymphocytes (Cohen, 1989)].
Although our studies did not demonstrate dexam-
ethasone-induced apoptosis in cultured TM cells, it is
possible that the cells we used were not responsive to
steroids. Studies using TM cells obtained from eyes
that have been proven susceptible to steroid-induced
glaucoma may elucidate whether apoptosis can be
induced in such cells.
The large number of mitochondria observed in
dexamethasone-treated cells is indicative of elevated
metabolic activity. These findings are consistent with
previous observations in steroid-treated TM cells
(Rohen, Linner and Witmer, 1973; Clark et al., 1995).
Whether exposure to anti-glaucoma medications
plays a role in decreased TM cellularity in vivo cannot
528 S. A. B. SIBAYAN ET AL.
be determined from this study. However, our findings
demonstrate that cultured TM cells can undergo
apoptosis when exposed to 5-FU, MMC and epi-
nephrine. While timolol, pilocarpine and dexametha-
sone did not induce apoptosis, they can incite
characteristic morphologic changes in TM cells in
vitro.
Acknowledgements
The authors thank Dr Salvador Gonza! lez for his commentson the manuscript. This study was supported by a grantfrom the Office of Naval Research (MFEL Grant No. N00014-94-I-0927).
References
Afanas’ev V. N., Korol, B. A., Mantsygin, Y. A., Nelipovich,P. A., Pechatnikov, V. A. and Umansky, S. R. (1986).Flow cytometry and biochemical analysis of DNAdegradation characteristic of two types of cell death.FEBS Lett. 194, 347–50.
Alvarado, J., Murphy, C. and Juster, R. (1984). Trabecularmeshwork cellularity in primary open-angle glaucomaand non-glaucomatous normals. Ophthalmology 91,564–79.
Armaly, M. F. (1963). Effect of corticosteroids on intraocularand fluid dynamics. I. The effect of dexamethasone inthe normal eye. Arch. Ophthalmol. 70, 482–91.
Barry, M. A., Behnke, C. A. and Eastman, A. (1990).Activation of programmed cell death (apoptosis) bycisplatin, other anticancer drugs, toxins and hyper-thermia. Biochem. Pharmacol. 40, 2353–62.
Becker, B. and Mills, D. W. (1963). Corticosteroids andintraocular pressure. Arch. Ophthalmol. 70, 500–7.
Bernstein, H. N. and Schwartz, B. (1962). Effects of long-term systemic steroids on ocular pressure and tono-graphic values. Arch. Ophthalmol. 68, 742–53.
Chen, C. W., Huang, H. T., Bair, J. S. and Lee, C. C. (1990).Trabeculectomy with simultaneous topical applicationof mitomycin C in refractory glaucoma. J. Ocul.Pharmacol. 6, 175–82.
Cidlowski, J. A. and Cidlowski, N. B. (1981). Glucocorticoideffects on HeLa S
$cell growth and thymidine in-
corporation. Cancer Res. 41, 2687–91.Clark, A. F., Wilson, K., de Kater, A. W., Allingham, R. R.
and McCartney, M. D. (1995). Dexamethasone-inducedocular hypertension in perfusion-cultured human eyes.Invest. Ophthalmol. Vis. Sci. 36, 478–89.
Cohen, J. J. (1989). Lymphocyte death induced by gluco-corticoids. In Anti-inflammatory steroid action. (Schlei-mer, R. P., Claman, H. N. and Oronsky, A. L. eds). Pp.110–31. Academic Press, Inc. : San Diego, U.S.A.
Cohen, J. J. and Duke, R. C. (1984). Glucocorticoid activationof a calcium-dependent endonuclease in thymocytenuclei leads to cell death. J. Immunol. 132, 38–42.
Coles, H. S. R., Burne, J. F. and Raff, M. C. (1993). Large-scale normal cell death in the developing rat kidney andits reduction by epidermal growth factor. Development118, 777–84.
Compton, M. M. and Cidlowski, J. A. (1986). Rapid in vivoeffects of glucocorticoids in the integrity of rat lym-phocyte genomic deoxyribonucleic acid. Endocrinology118, 38–45.
Don, M. M., Ablett, G., Bishop, C. J., Bundesen, P. G., Donald,K. J., Searle, J. and Kerr, J. F. R. (1977). Death of cellsby apoptosis following attachment of specifically aller-gized lymphocytes in vitro. Aust. J. Exp. Biol. Med. Sci.55, 407–17.
Duvall, E. and Wyllie, A. H. (1986). Death and the cell.Immunol. Today 7, 115–9.
Ellis, P. P., Matsumura, M. and Rendi, M. A. (1985).Pilocarpine concentrations in aqueous humor followingsingle drop application: I. Effect of soft contact lenses.Curr. Eye Res. 4, 1041–7.
Ellis, P. P., Wu, P. Y. and Riegel, M. (1991). Aqueous humorpilocarpine and timolol levels after instillation of thesingle drug or in combination. Invest. Ophthalmol. Vis.Sci. 32, 520–2.
Fantes, F. E., Parrish, R. K., Heuer, D. K. and Sossi, N.(1987). Subconjunctival 5-fluorouracil mechanisms ofocular penetration. Ophthalmic Surg. 18, 375–8.
Grierson, I., Wang, Q., McMenamin, P. G. and Lee, W. R.(1982). The effects of age and antiglaucoma drugs onthe meshwork cell population. Res. Clin. Forums. 4(5),69–92.
Hassan, A. H. S., Von Rosenstiel, P., Patchev, V. K.,Holsboer, F. and Almeida, O. F. X. (1996). Exacerbationof apoptosis in the dentate gyrus of the aged rat bydexamethasone and the protective role of cortico-sterone. Exp. Neurol. 140, 43–52.
Heuer, D. K., Parrish, R. K., Gressel, M. G., Hodapp, E.,Desjardins, D. C., Skuta, G. L., Palmberg, P. F., Neva! rez,J. A. and Rockwood, E. J. (1986). 5-Fluorouracil andglaucoma filtering surgery: III. Intermediate follow-upof a pilot study. Ophthalmology 93, 1537–46.
Kaufman, P. L. and Rentzhog, L. (1981). Effect of totaliridectomy on outflow facility responses to adrenergicdrugs in cynomolgus monkeys. Exp. Eye Res. 33,65–74.
Kawa, J. E., Higginbotham, E. J., Chang, I. L. and Yue,B. Y. J. T. (1993). Effects of antiglaucoma medicationson bovine trabecular meshwork cells in vitro. Exp. EyeRes. 57, 557–65.
Kawabori, S., Soda, K., Perdue, M. H. and Bienenstock, J.(1991). The dynamics of intestinal eosinophil depletionin rats treated with dexamethasone. Lab. Invest. 64,224–33.
Kawase, K., Matsushita, H., Yamamoto, T. and Kitazawa, Y.(1992). Mitomycin concentration in rabbit and humanocular tissues after topical administration. Ophthal-mology 99, 203–7.
Kerr, J. F. R., Wyllie, A. H. and Currie, A. R. (1972).Apoptosis : A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26,239–57.
Kerr, J. F. R., Searle, J., Harmon, B. V. and Bishop, C. J.(1987). Apoptosis. In Perspectives on mammalian celldeath (Potten, C. S. ed). Pp. 93–128. Oxford UniversityPress : New York, U.S.A.
Lowe, S. W., Ruley, H. E., Jacks, T. and Housman, D. E.(1993). p53-Dependent apoptosis modulates the cyto-toxicity of anticancer agents. Cell 74, 957–67.
McConkey, D. J., Aguilar-Santelises, M., Hartzell, P.,Eriksson, I., Mellstedt, H., Orrenius, S. and Jondal, M.(1991). Induction of DNA fragmentation in chronicB-lymphocytic leukemia cells. J. Immunol. 146, 1072–6.
McConkey, D. J., Orrenius, S. and Jondal, M. (1990). Agentsthat elevate cAMP stimulate DNA fragmentation inthymocytes. J. Immunol. 145, 1227–30.
Ohmori, T., Podack, E. R., Nishio, K., Takahashi, M.,Miyahara, Y., Takeda, Y., Kubota, N., Funayama, Y.,Ogasawara, H., Ohira, T., Ohta, S. and Saijo, N. (1993).Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. Biochem. Biophys. Res. Commun. 192, 30–6.
Palmer, S. S. (1991). Mitomycin as adjunct chemotherapywith trabeculectomy. Ophthalmology 98, 317–21.
Polansky, J. R. and Alvarado, J. A. (1985). Isolation andevaluation of target cells in glaucoma research:
DRUG-INDUCED APOPTOSIS IN TRABECULAR CELLS 529
hormone receptors and drug responses. Curr. Eye. Res.4, 267–79.
Rey, J. P., Scott, R. and Mu$ ller, H. (1994). Apoptosis is notinvolved in the hypersensitivity of Fanconi anemia cellsto mitomycin C. Cancer Genet. Cytogenet. 75, 67–71.
Rinner, I., Kukulansky, T., Skreiner, E., Globerson, A., Kasai,M., Hirokawa, K. and Schauenstein, K. (1994).Adrenergic and cholinergic regulation of apoptosis anddifferentiation of thymic lymphocytes. Adv. Exp. Med.Biol. 355, 113–17.
Rohen, J. W., Linner, E. and Witmer, R. (1973). Electronmicroscopic studies on the trabecular meshwork in twocases of corticosteroid glaucoma. Exp. Eye Res. 17,19–31.
Rootman, J., Tisdall, J., Gudauskas, G. and Ostry, A. (1979).Intraocular penetration of subconjunctivally admini-stered "%C-fluorouracil in rabbits. Arch. Ophthalmol. 97,2375–8.
Schwartzman, R. A. and Cidlowski, J. A. (1991). Inter-nucleosomal deoxyribonucleic acid cleavage activity inapoptotic thymocytes : Detection and endocrine regu-lation. Endocrinology 128, 1190–7.
Schwartzman, R. A. and Cidlowski, J. A. (1993). Apoptosis :The biochemistry and molecular biology of programmedcell death. Endocrine. Rev. 14, 133–51.
Seah, S. K. L., Prata, J. A., Minckler, D. S., Koda, R. T.,
Baerveldt, G., Lee, P. P. and Heuer, D. K. (1993).Mitomycin-C concentration in human aqueous humorfollowing trabeculectomy. Eye 7, 652–5.
Searle, J., Lawson, T. A., Abbott, P. J., Harmon, B. and Kerr,J. F. R. (1975). An electron-microscope study of themode of cell death induced by cancer-chemotherapeuticagents in populations of proliferating normal andneoplastic cells. J. Pathol. 116, 129–38.
Tripathi, B. J., Tripathi, R. C. and Millard, C. B. (1989).Epinephrine-induced toxicity of human trabecular cellsin vitro. Lens Eye Toxic. Res. 6, 141–56.
Watson, P. G. and Grierson, I. (1981). The place oftrabeculectomy in the treatment of glaucoma. Ophthal-mology 88, 175–96.
Watson, D., Noble, M. J., Dutton, G. N., Midgley, J. M. andHealey, T. M. (1988). Penetration of topically applieddexamethasone alcohol into human aqueous humor.Arch. Ophthalmol. 106, 686–7.
Wyllie, A. H. (1980). Glucocorticoid-induced thymocyteapoptosis is associated with endogenous endonucleaseactivation. Nature 284, 555–6.
Zysk, G., Bru$ ck, W., Gerber, J., Bru$ ck, Y., Prange, H. W. andNau, R. (1996). Anti-inflammatory treatment influ-ences neuronal apoptotic cell death in the dentate gyrusin experimental pneumococcal meningitis. J. Neuro-pathol. Exp. Neurol. 55, 722–8.